Notable companies
The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Amgen (NASDAQ:AMGN), Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Exact Sciences Corp (NASDAQ:EXAS), Teladoc Health (NYSE:TDOC), Guardant Health (NASDAQ:GH), Adaptive Biotechnologies Corp (NASDAQ:ADPT).
Industry description
The investment seeks long-term growth of capital.
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
Market Cap
The average market capitalization across the ARK Genomic Revolution ETF ETF is 103.68B. The market cap for tickers in the group ranges from 9.71M to 3.62T. NVDA holds the highest valuation in this group at 3.62T. The lowest valued company is SNTI at 9.71M.
High and low price notable news
The average weekly price growth across all stocks in the ARK Genomic Revolution ETF ETF was 32%. For the same ETF, the average monthly price growth was 48%, and the average quarterly price growth was 230%. BFLY experienced the highest price growth at 29%, while EXAS experienced the biggest fall at -26%.
Volume
The average weekly volume growth across all stocks in the ARK Genomic Revolution ETF ETF was -2%. For the same stocks of the ETF, the average monthly volume growth was -10% and the average quarterly volume growth was -33%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 52
P/E Growth Rating: 84
Price Growth Rating: 49
SMR Rating: 88
Profit Risk Rating: 86
Seasonality Score: 35 (-100 ... +100)